Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 3 Gynecologic 2 Gastrointestinal 2 CNS 2 Thoracic 1 Other solid neoplasm 1 Lymphoid 1 Genitourinary 1 Dermatologic 1 Classical hematology 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 132 Cisplatin 129 Pemetrexed 114 Docetaxel 81 Drug Therapy 62 Gefitinib 57 anlotinib 55 Gemcitabine 55 Erlotinib Hydrochloride 55 Radiotherapy 48 Bevacizumab 48 pembrolizumab 47 Paclitaxel 47 Etoposide 44 apatinib 42 icotinib 41 camrelizumab 39 osimertinib 36 Nivolumab 33 Vinorelbine 31 Radiosurgery 30 sintilimab 29 durvalumab 25 aumolertinib 25 endostar protein 24 atezolizumab 22 Endostatins 22 toripalimab 19 Blood Specimen Collection 19 tislelizumab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Genetic Testing × Thoracic × Clear all

NCT02299622 2021-03-19

Personalized Sequence for Thoracic, Esophageal, and H&N Cancer

Samsung Medical Center

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡